Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Celanese Says Mark Rohr Assumed Chairman And CEO Roles - Quick Facts

RELATED NEWS
Trade CE now with 

Celanese Corp. (CE: Quote) said Mark Rohr has assumed the roles of chairman and chief executive officer. He will be based at Celanese's corporate headquarters in Dallas, Texas.

Rohr was named by the Celanese Board of Directors in November 2011 to succeed David Weidman, who officially retired April 2, 2012.

Prior to assuming his new roles, Rohr visited Celanese sites and customers around the world including Asia, Europe and the Middle East. He will continue engaging with customers and other key stakeholders through aggressive outreach including a corporate blog, mobile applications and new website to be introduced later this year.

Rohr, a member of Celanese's Board of Directors since 2007, earlier held the positions of chief executive officer and chairman of Albemarle Corp., as well as executive chairman of its Board.

Click here to receive FREE breaking news email alerts for Celanese Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. With traders seemingly reluctant to make any significant moves, stocks continue to show a lack of direction in mid-day trading on Friday. Nonetheless, the markets are largely holding on to the bulk of their recent gains. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.